Mass Torts Update - Written by Beasley Allen on Thursday, February 9, 2012 8:00 - 5 Comments
The following is a requested update on the Reglan litigation in Philadelphia. Even though a state trial judge there has overruled generic drug manufacturers’ preliminary objections seeking dismissal of the claims asserted against them, the viability of the Plaintiffs’ claims are still in question and could be subject to further delay. Recently, generic drug manufacturers involved in the Philadelphia litigation jointly filed a petition for permission to appeal Judge Moss’ order to the Superior Court of Pennsylvania.
Under Pennsylvania law, the Defendants are permitted to appeal under sections 702(b) and 742 of the Pennsylvania Judicial Code when there is an order involving a controlling question of law to which there is a substantial ground for difference of opinion that an immediate appeal from the order may materially advance the ultimate determination of the matter. Here, the controlling question of law is whether, under Mensing, Plaintiffs’ claims against generic Defendants are preempted by federal law.
Many courts, including the 5th, 6th, and 8th Circuit Courts of Appeal, as well as district courts in Louisiana, Arkansas, Florida, Indiana, Georgia and New Jersey, have all dismissed state law claims raised against generic drug manufacturers. To add further support to their argument that appeal is proper under the circumstances, the generic Defendants also argue that Judge Moss’ decision was a collateral order separable from and collateral to the main cause of action, making the issue immediately appealable.
Plaintiffs who have filed suit around the country contend that Mensing may preempt failure to warn claims, but that does not imply that Mensing granted generics immunity from all tort liability. Specifically, generics are not preempted from failing to adequately communicate warnings that are consistent with information found in the labeling of its brand-name counterpart. In fact, it was alleged before the trial court in Philadelphia that no Reglan manufacturer, generic or brand, communicated the 2004 label changes, which specifically warned that drug therapy with Reglan/metoclopramide should not exceed twelve weeks, to physicians. It was this failure to communicate that led to the chronic over-prescribing of the drug and the multitude of injuries that resulted.
After Judge Moss’ ruling, the bellwether trial process reconvened in Philadelphia with the first trial set to begin in May 2012. It is unknown at this time whether the generics’ petition for appeal will disrupt the upcoming trial settings. If you need more information on this subject, contact Danielle Mason at 800-898-2034 or by email at Danielle.Mason@beasleyallen.com. Danielle has been actively involved in this litigation.
Leave a Reply
- Testosterone Multidistrict Litigation Has Been Formed
- Exploding Airbags is the Next Hidden Danger Lurking on the Horizon
- Favorite Bible Verses
- An Update on the Firm's Mass Torts Litigation
- The Civil Justice System Does Make a Difference
- BP's Stay Request Fails Before the Supreme Court
- Eight Car Makers Join in the Recall of Exploding Airbags
- The Deepwater Horizon Claims Program is Up and Running Again
- Favorite Bible Verses
- J&J Pays Oregon $4 Million To Settle Hip Implant Marketing Claims
- EPA Should Update Fracking Pollution Regulations
- Deepwater Fracking Raises Environmental Concerns
- $27.8 Million Settlement Finalized In TVA Coal Ash Spill
- Illinois Transport Company Settles Fatal Crash Suit For $2.7 Million
- Settlement For Family Of College Student Killed In Crash After Alabama National Championship Game
- Macy’s Fined $1 Million For Decapitation Of Warehouse Employee
- Texas Plastics Plant Fined $174,000 For Safety And Health Violations
- OSHA Says Safety Violation Continue At Oklahoma Oil Refinery
- Company Cited In Fatal West Virginia Cell Tower Collapse
- New Safety Directive Issued By OSHA On Communication Tower Work
- $27 Million Verdict Returned In Texas Against McDonald’s
- Was just wondering if you can still be in this lawsuit. I was a manager for 8 yr...
- I keep reading that the pratice of steering is illegal and whole-heartidly suppo...
- Hello William, thank you for your question. We are not aware of any pending liti...
- Has litigation commenced as a result of this recall?...
- Sorry I meant to say settlement papers, but I did speak to someone in the Lawyer...
- I just spoke to someone and was told it will be another month or two before I wi...
- 2005 F150 super cab. Driver side regulator just broke. Dealer wants $200 just fo...
- Today, the 4th window failed in my 2004 F-150 SuperCrew - I bought it new and th...
Recent Settlements - Feb 9, 2012 7:09 - 0 Comments
More In Recent Settlements
- A Further Update On The AWP Litigation
- Firm Reaches Settlement In Fort McClellan Radio Tower Collapse Case
- Firm Reaches Settlement In Sikorsky Helicopter Crash
- The Philadelphia Story
- St. Croix, Virgin Islands Settlement
Product Liability - Sep 4, 2014 13:13 - 0 Comments
More In Product Liability
- More Problems With Goodyear RV Tires
- NHTSA Offers Online Vehicle Recall Check
- Class Action Lawsuit Filed Against Mazda For Engine Valve Defect
- GM Sued For Alleged Antifreeze Defect In Chevy Cruze Models
- Settlement By Kia And Hyundai In Fuel Efficiency MDL Is Approved
Recalls Update - Sep 4, 2014 11:03 - 0 Comments
More In Recalls Update
- USDA Recalls 7.5 Tons Of Applegate Frozen Chicken Nuggets
- J&J Unit Recalls Hysterectomy Device Over Cancer Fears
- Samson International Recalls Bar Stool Due To Fall Hazard
- Bexco Recalls Franklin & Ben Mason 4-in-1 Convertible Cribs Due To Fall And Entrapment Hazards
- Ace Bayou Bean Bag Chairs Recalled Because Of Suffocation And Choking Hazards